Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Workup and management of patients with syncope
1995
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
1992 Standout
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
1998 Standout
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 Standout
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
2002 Standout
Survival of Cardiac Arrest after Aneurysmal Subarachnoid Hemorrhage
2005
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
1995 Standout
Users' Guides to the Medical Literature
1999 Standout
Primary Pulmonary Hypertension
1997 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Survival in Patients with Primary Pulmonary Hypertension
1991 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
1992 Standout
The Evaluation and Management of Bradycardia
2000
Electrocardiographic Changes in Patients with Acute Stroke: A Systematic Review
2002
Effects of fibrates on serum lipids and atherosclerosis
1988
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Gemfibrozil
1988
Subarachnoid haemorrhage
2007 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Long-lasting sport practice and lone atrial fibrillation
2002
Incidence and Prognosis of Syncope
2002 Standout
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
1995 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
2005 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Analgesic nephrotoxicity
1964 StandoutNobel
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mitogen Stimulation of Splenocytes from Mice Infected with Scrapie Agent
1978 StandoutNobel
Magnesium in Man: Implications for Health and Disease
2014 Standout
Lactic Dehydrogenase Virus
1975
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Capturing Magnesium Ions via Microfluidic Hydrogel Microspheres for Promoting Cancellous Bone Regeneration
2021 Standout
Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits
2004 Standout
Role of endocrine factors in chronic congestive heart failure, with emphasis on catecholamines.
1980
The long Q-T syndrome
1975
HYPERTENSION, CARDIAC ARRHYTHMIAS, MYOCARDIAL INFARCTION, AND STROKE IN RELATION TO OBSTRUCTIVE SLEEP APNEA
1992
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
Clinical results with gemfibrozil and background to the Helsinki Heart Study
1983
The Nephrotoxicity of Analgesic Abuse
1962
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
1989 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Chronic Renal Disease and Heavy use of Analgesics
1963
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Dietary and Drug Treatment of Primary Hyperlipoproteinemia
1972
CLINICAL GUIDELINE: Diagnosing Syncope: Part 2: Unexplained Syncope
1997
Occurrence of drugs in German sewage treatment plants and rivers
1998 Standout
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Steroid Induction of Porphyrin Synthesis in Liver Cell Culture
1968
Substrate-inducible Microsomal Aryl Hydroxylase in Mammalian Cell Culture
1968 Standout
CARDIOVASCULAR EFFECTS OF ?-ADRENORECEPTOR BLOCKING AGENTS AFTER INTRACEREBROVENTRICULAR ADMINISTRATION IN CONSCIOUS NORMOTENSIVE CATS
1974
Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil
1998 StandoutNobel
Survival in second degree atrioventricular block.
1985
Steroid Induction of Porphyrin Synthesis in Liver Cell Culture
1967
Cardiovascular Evaluation of the Athlete
1997
Atrial fibrillation after acute stroke.
1993
Renal Toxicity of Non-Steroidal Anti-Inflammatory Drugs
1986
Mechanism of action of gemfibrozil on lipoprotein metabolism.
1985
Epidemiology of coronary heart disease: The Framingham study
1984
ORAL CONTRACEPTIVES AND PROGRESSIVE PULMONARY VASCULAR DISEASE
1968
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
1982 Standout
REDUCED ADRENAL AMINE SYNTHESIS IN SPONTANEOUSLY HYPERTENSIVE RATS AFTER LONG‐TERM TREATMENT WITH PROPRANOLOL
1977 StandoutNobel
Renal Damage Associated with Chronic Phenacetin Overdosage
1962
Free Radicals in the Physiological Control of Cell Function
2002 Standout
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.
1987
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Works of A Eisalo being referenced
Hepatic Impairment During the Intake of Contraceptive Pills: Clinical Trial with Postmenopausal Women
1964
Sleep and Cardiac Rhythm in Healthy Men
1991
Ambulatory electrocardiographic recording in endurance athletes.
1982
Syncope and Q-T prolongation without deafness: The Romano-Ward syndrome
1970
Electrocardiographic abnormalities and some laboratory findings in patients with subarachnoid haemorrhage.
1972
Ambulatory ECG Recording in Patients Referred because of Syncope or Dizziness
1982
Observations on the Effect of Phenacetin and N‐acetyl‐p‐aminophenol on Rat Kidneys
1961
Extrinsic Factors Affecting the Response to Gemfibrozil
1976
Effect of Short-Term Upright Posture on Plasma Angiotensin II in Man
1974
TURNOVER OF 35S-LABELLED SERUM ALBUMIN AND GAMMA GLOBULIN IN THE RAT: COMPARISON OF THE RESOLUTION OF PLASMA RADIOACTIVITY CURVES BY GRAPHIC MEANS (MANUALLY) AND BY COMPUTER.
1964
Gemfibrozil and Clofibrate in the Treatment of Hyperlipidæmias. A Comparative Trial
1976
A Long-term Trial of Gemfibrozil in the Treatment of Hyperlipidæmias
1976
Treatment of Hyperlipidemia with d‐Thyroxine
1963
HAEMODYNAMIC EFFECTS OF TRASICOR®, A NEW BETA‐ADRENERGIC BLOCKING AGENT, IN HYPERTENSIVE PATIENTS
1969
Hypolipidæmic Action of Gemfibrozil in Adult Nephrotics
1976
Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up study
1982
Urinary Excretion of Porphyrin Precursors and Coproporphyrin in Healthy Females on Oral Contraceptives
1966
Potassium and Magnesium Balance in Thiazide‐Treated Cardiac Patients with Special Reference to Diet
1982